H&T Group PLC Statement regarding Finance Director Steve Fenerty (9206E)
February 14 2018 - 11:35AM
UK Regulatory
TIDMHAT
RNS Number : 9206E
H&T Group PLC
14 February 2018
14(th) February 2018
H&T Group plc
("H&T" or "the Group" or "the Company")
Statement regarding Finance Director, Steve Fenerty
The Board of H&T Plc announces that its Finance Director,
Steve Fenerty, has recently been diagnosed with leukaemia. He is
receiving first class treatment and remains actively involved with
the running of the business.
Peter McNamara, Chairman said, "We have a clear strategy headed
by CEO John Nichols. Steve Fenerty is well supported by Tatiana
Hagan, part of a first class finance team he has developed over
recent years. Steve Fenerty will have further assistance given by
an interim appointment from an experienced Financial Officer from
within the sector.
We all wish Steve well in his treatment and recovery."
- ENDS -
Enquiries:
H&T Group plc
Tel: 0870 9022 600
John Nichols, chief executive
Steve Fenerty, finance director
Numis Securities (broker and nominated adviser)
Tel: 020 7260 1000
Mark Lander, corporate broking
Freddie Barnfield, nominated adviser
Haggie Partners (public relations)
Tel: 020 7562 4444
Damian Beeley
Brian Norris
This information is provided by RNS
The company news service from the London Stock Exchange
END
STRSFEFMLFASEEE
(END) Dow Jones Newswires
February 14, 2018 11:35 ET (16:35 GMT)
H&t (LSE:HAT)
Historical Stock Chart
From May 2024 to Jun 2024
H&t (LSE:HAT)
Historical Stock Chart
From Jun 2023 to Jun 2024